Electrovestibulography (EVestG) for Post-concussion syndrome (PCS)

  • Home
  • /
  • Electrovestibulography (EVestG) for Post-concussion syndrome (PCS)

Electrovestibulography (EVestG) for Post-concussion syndrome (PCS)

Fishman comment:  Post-concussion syndrome (PCS) is a very debilitating condition in which individuals suffer from symptoms including “headaches, dizziness, fatigue, irritability, reduced concentration, sleep disturbance, memory loss, sensitivity to noise or light, double or blurred vision, nausea, anxiety and depression.” Electrovestibulography (EVestG) is an objective diagnostic tool for PCS. It is an important development because it provides objective parameters to allow patients gauge their progression to recovery.

However, one of the challenges in treating PCS is co-morbid depression that may interfere with gauging whether clinical improvement is occurring. This brilliant and heady Nature paper “showed that when depression and PCS are co-morbid in a PCS group, the EVestG features could be used to detect both conditions with two different and relatively independent neurophysiological mechanisms that can be applied simultaneously.”

Title: “Investigating the validity and reliability of Electrovestibulography (EVestG) for detecting post- concussion syndrome (PCS) with and without comorbid depression. Sci Rep 8, 14495 (2018). https://doi.org/10.1038/s41598-018-32808-1.

Authors: Suleiman, A., Lithgow, B., Mansouri, B. et al. Investigating the validity and reliability of Electrovestibulography (EVestG) for detecting post-concussion syndrome (PCS) with and without comorbid depression.

Abstract: Features from Electrovestibulography (EVestG) recordings have been used to classify and measure the severity of both persistent post-concussion syndrome (PCS) and major depressive disorder. Herein, we examined the effect of comorbid depression on the detection of persistent PCS using EVestG. To validate our previously developed EVestG classifier for PCS detection, the classifier was tested with a new blind dataset (N = 21). The unbiased accuracy for identifying the new PCS from controls was found to be >90%. Next, the PCS group (N = 59) was divided into three subgroups: PCS with no-depression (n = 18), PCS with mild-depression (n = 27) and PCS with moderate/severe-depression (n = 14). When moderate/severe depression was present, PCS classification accuracy dropped to 83%. By adding an EVestG depression feature from a previous study, separation accuracy of each PCS subgroup from controls was >90%. A four and three-group (excluding mild-depression subgroup) classification, achieved an accuracy of 74% and 81%, respectively. Correlation analysis indicated a significantcorrelation (R = 0.67) between the depression feature and the MADRS depression score as well as between the PCS-specific feature and Rivermead Post-Concussion Questionnaire (RPQ) (R = −0.48). No significant correlation was found between the PCS-specific feature and the MADRS score (R = 0.20) or between RPQ and the depression feature (R = 0.12). The (PCS-specific and depression-specific) EVestG features used herein have the potential to robustly detect and monitor changes, relatively independently, in both persistent PCS and its depression comorbidity. Clinically, this can be particularly advantageous.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.